126 related articles for article (PubMed ID: 37658767)
21. Hyperuricemia as a clue for central diabetes insipidus (lack of V1 effect) in the differential diagnosis of polydipsia.
Decaux G; Prospert F; Namias B; Soupart A
Am J Med; 1997 Nov; 103(5):376-82. PubMed ID: 9375705
[TBL] [Abstract][Full Text] [Related]
22. Central diabetes insipidus related to anti-programmed cell-death 1 protein active immunotherapy.
Deligiorgi MV; Siasos G; Vergadis C; Trafalis DT
Int Immunopharmacol; 2020 Jun; 83():106427. PubMed ID: 32244049
[TBL] [Abstract][Full Text] [Related]
23. Treatment of neurogenic diabetes insipidus.
Chanson P; Salenave S
Ann Endocrinol (Paris); 2011 Dec; 72(6):496-9. PubMed ID: 22071315
[TBL] [Abstract][Full Text] [Related]
24. Central Diabetes Insipidus after Syndrome of Inappropriate Antidiuretic Hormone Secretion with Severe Hyponatremia in a Patient with Rathke's Cleft Cyst.
Hinata Y; Ohara N; Komatsu T; Sakurai Y; Yoneoka Y; Seki Y; Akiyama K; Sone H
Intern Med; 2022 Jan; 61(2):197-203. PubMed ID: 34248116
[TBL] [Abstract][Full Text] [Related]
25. The Impact of a Standardized Sodium Protocol on Incidence and Outcome of Dysnatremias in Neurocritical Care.
Spatenkova V; Bradac O; Skrabalek P
J Neurol Surg A Cent Eur Neurosurg; 2015 Jul; 76(4):279-90. PubMed ID: 25539069
[TBL] [Abstract][Full Text] [Related]
26. Central diabetes insipidus.
Arima H; Azuma Y; Morishita Y; Hagiwara D
Nagoya J Med Sci; 2016 Dec; 78(4):349-358. PubMed ID: 28008190
[TBL] [Abstract][Full Text] [Related]
27. Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy.
Smego AR; Backeljauw P; Gutmark-Little I
J Clin Endocrinol Metab; 2016 May; 101(5):2084-8. PubMed ID: 27011115
[TBL] [Abstract][Full Text] [Related]
28. Double Trouble - Severe Hypernatremia Secondary to Central Diabetes Insipidus Complicated by Hypercalcemic Nephrogenic Diabetes Insipidus: A Case Report.
Zain MA; Raza A; Hanif MO; Tauqir Z; Khan M; Mahboob MJ; Ashraf F; Siddiqui WJ; Arif H; Krevolin LE
Am J Case Rep; 2018 Aug; 19():973-977. PubMed ID: 30120219
[TBL] [Abstract][Full Text] [Related]
29. AVP deficiency (central diabetes insipidus) following immunization with anti-COVID-19 BNT162b2 Comirnaty vaccine in adolescents: A case report.
Partenope C; Pedranzini Q; Petri A; Rabbone I; Prodam F; Bellone S
Front Endocrinol (Lausanne); 2023; 14():1166953. PubMed ID: 37143723
[TBL] [Abstract][Full Text] [Related]
30. A new fast-melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresis.
Vande Walle JG; Bogaert GA; Mattsson S; Schurmans T; Hoebeke P; Deboe V; Norgaard JP;
BJU Int; 2006 Mar; 97(3):603-9. PubMed ID: 16469035
[TBL] [Abstract][Full Text] [Related]
31. A Rare Case of Familial Neurogenic Diabetes Insipidus in a 22-Year-Old Man.
Phan VTT; Bloomer ZW; Phan VTX; Shakir MKM; Hoang TD
AACE Clin Case Rep; 2021; 7(6):338-341. PubMed ID: 34765727
[TBL] [Abstract][Full Text] [Related]
32. Neurosarcoidosis-associated central diabetes insipidus masked by adrenal insufficiency.
Non L; Brito D; Anastasopoulou C
BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25612752
[TBL] [Abstract][Full Text] [Related]
33. Central diabetes insipidus and heart: effect of acute arginine vasopressin deficiency and replacement treatment with desmopressin on cardiac performance.
Pivonello R; Faggiano A; Arrichiello P; Di Sarno A; Di Somma C; Ferone D; Lombardi G; Colao A
Clin Endocrinol (Oxf); 2001 Jan; 54(1):97-106. PubMed ID: 11167932
[TBL] [Abstract][Full Text] [Related]
34. A randomised comparison of oral desmopressin lyophilisate (MELT) and tablet formulations in children and adolescents with primary nocturnal enuresis.
Lottmann H; Froeling F; Alloussi S; El-Radhi AS; Rittig S; Riis A; Persson BE
Int J Clin Pract; 2007 Sep; 61(9):1454-60. PubMed ID: 17655682
[TBL] [Abstract][Full Text] [Related]
35. Management of diabetes insipidus in children.
Mishra G; Chandrashekhar SR
Indian J Endocrinol Metab; 2011 Sep; 15 Suppl 3(Suppl3):S180-7. PubMed ID: 22029022
[TBL] [Abstract][Full Text] [Related]
36. National Surveillance of Central Diabetes Insipidus (CDI) in Denmark: results from 5 years registration of 9309 prescriptions of desmopressin to 1285 CDI patients.
Juul KV; Schroeder M; Rittig S; Nørgaard JP
J Clin Endocrinol Metab; 2014 Jun; 99(6):2181-7. PubMed ID: 24527719
[TBL] [Abstract][Full Text] [Related]
37. Severe hyperosmolarity and hypernatremia in an adipsic young woman.
Latcha S; Lubetzky M; Weinstein AM
Clin Nephrol; 2011 Nov; 76(5):407-11. PubMed ID: 22000562
[TBL] [Abstract][Full Text] [Related]
38. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
39. Congenital nephrogenic diabetes insipidus presenting as osmotic demyelination syndrome in infancy: A case report.
Kobayashi S; Mizuno N; Yokoi K; Mori T; Sohara E; Uchida S
Medicine (Baltimore); 2022 Jan; 101(3):e28552. PubMed ID: 35060513
[TBL] [Abstract][Full Text] [Related]
40. Idiopathic central diabetes insipidus in an extreme premature infant: A case report.
Biset A; Claris O
Arch Pediatr; 2018 Nov; 25(8):480-484. PubMed ID: 30361085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
